Mycoplasma genitalium: An emergent sexually transmitted disease?

Lisa E Manhart

doi:10.1016/j.idc.2013.08.003

Mycoplasma genitalium: An emergent sexually transmitted disease?

Infect Dis Clin North Am. 2013 Dec;27(4):779-92. doi: 10.1016/j.idc.2013.08.003. Epub 2013 Oct 25.

Author

Lisa E Manhart¹

Affiliation

¹ Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: lmanhart@u.washington.edu.

PMID: 24275270
DOI: 10.1016/j.idc.2013.08.003

Abstract

This article summarizes the epidemiologic evidence linking Mycoplasma genitalium to sexually transmitted disease syndromes, including male urethritis, and female cervicitis, pelvic inflammatory disease, infertility, and adverse birth outcomes. It discusses the relationship of this bacterium to human immunodeficiency virus infection and reviews the available literature on the efficacy of standard antimicrobial therapies against M genitalium.

Keywords: Cervicitis; Mycoplasma genitalium; NGU; Pelvic inflammatory disease; STD; STI; Urethritis.

Publication types

Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Communicable Diseases, Emerging / complications
Communicable Diseases, Emerging / drug therapy
Communicable Diseases, Emerging / microbiology*
Female
Humans
Male
Mycoplasma Infections / complications
Mycoplasma Infections / drug therapy
Mycoplasma Infections / microbiology*
Mycoplasma genitalium*
Sexually Transmitted Diseases, Bacterial / complications
Sexually Transmitted Diseases, Bacterial / drug therapy
Sexually Transmitted Diseases, Bacterial / microbiology*

Substances

Anti-Bacterial Agents